IVAC_M_uID / BioNTech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IVAC_M_uID / BioNTech
TNBC-MERIT, NCT02316457: RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID

Completed
1
42
Europe
IVAC_W_bre1_uID, IVAC_W_bre1_uID/IVAC_M_uID
BioNTech SE, Seventh Framework Programme
Breast Cancer (Triple Negative Breast Cancer (TNBC))
05/20
05/23

Download Options